Treating rare blood clots related to J&J COVID vaccine following usage suspension: new guidance
By
Alicia Lasek
Apr 28, 2021
Advisers to the CDC have released new clinical guidance and education regarding a rare blood clotting condition reported after vaccination.
‘Already skeptical’ nursing home workers may need persuading after J&J shots resume, industry leaders...
By
Danielle Brown
Apr 26, 2021
Now that vaccinators are encouraged to resume giving Johnson & Johnson’s COVID-19 shot, nursing home stakeholders are questioning what effect the recent pause will have on vaccine uptake in a wary population.
Older adults who have received J&J need not be concerned: expert
By
Amy Novotney
Apr 20, 2021
Joshua Sharfstein, M.D., vice dean for public health practice and community engagement at Johns Hopkins University, has a message for older adults who have received the Johnson & Johnson COVID-19 vaccine:...
LTC vaccinators opt to briefly halt J&J shots while awaiting FDA guidance
By
Alicia Lasek
Apr 14, 2021
Long-term care pharmacies and clinicians have temporarily paused their use of Johnson & Johnson’s COVID vaccine following recommendations from health officials. Guidance is needed quickly in order to...
Clinical briefs for Friday, April 2
By
Alicia Lasek
Apr 02, 2021
New CDC data: Osteoporosis rates increase in women … Exposed to COVID? Study finds point-of-care antibody tests highly effective at detection … Ruined J&J coronavirus vaccine doses are not in circulation:...
J&J coronavirus shot nears U.S. approval with 66% efficacy, but data on elders limited
By
Alicia Lasek
Feb 25, 2021
There were no COVID-19-related deaths or cases requiring medical intervention four weeks or more after vaccination in adults age 60 and older. But there were not enough participants aged 75 and older to...
Makers of newer vaccines tout advantages as trial results and approvals announced
By
Alicia Lasek
Feb 01, 2021
Two drugmakers say their vaccines, which include J&J’s one-dose candidate, are effective against new coronavirus variants, while AstraZeneca’s vaccine is now approved for adults across the...
Clinical briefs for Thursday, Jan. 14
By
Alicia Lasek
Jan 14, 2021
Spanish judge orders that nursing home resident get coronavirus vaccine … Nearly 25% of first-round vaccine doses administered in long-term care … J&J’s COVID-19 vaccine expected to show over 80%...
Flooring group introduces plank products
Mar 10, 2015
J&J Flooring Group’s Kinetex textile has introduced its first modular plank products.
A tough retirement nest egg, the whistle-blowing way
By
James M. Berklan
Nov 07, 2013
Two big reactions hit me when news of Johnson & Johnson’s $2.2 billion Risperdal settlement with the government landed this week. First, J&J probably made a lot more than it’s paying out and,...